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ABSTRACT
Hypoxia and loss of cell polarity are common features of malignant
carcinomas. Hypoxia-inducible factor 1 (HIF1) is the major regulator
of cellular hypoxia response and mediates the activation of ∼300
genes. Increased HIF1 signaling is known to be associated with
epithelial–mesenchymal transformation. Here, we report that hypoxia
disrupts polarized epithelial morphogenesis of MDCK cells in a
HIF1α-dependent manner by modulating the transforming growth
factor-β (TGFβ) signaling pathway. Analysis of potential HIF1 targets
in the TGFβ pathway identified the bone morphogenetic protein and
activin membrane-bound inhibitor (BAMBI), a transmembrane
glycoprotein related to the type I receptors of the TGFβ family,
whose expression was essentially lost in HIF1-depleted cells. Similar
to what was observed in HIF1-deficient cells, BAMBI-depleted cells
failed to efficiently activate TGFβ signaling and retained epithelial
polarity during hypoxia. Taken together, we show that hypoxic
conditions promote TGFβ signaling in a HIF1-dependent manner and
BAMBI is identified in this pathway as a novel HIF1-regulated gene
that contributes to hypoxia-induced loss of epithelial polarity.
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INTRODUCTION
Hypoxia-inducible factors (HIFs) are transcription factors that
facilitate adaptation to oxygen deprivation by activating∼300 genes
involved in erythropoiesis, angiogenesis, anaerobic metabolism,
and cell differentiation and survival. HIFs are αβ heterodimers and
the stability of the α-subunit is regulated by oxygen-dependent
prolyl hydroxylation catalyzed by HIF prolyl 4-hydroxylases (HIF-
P4Hs, also known as PHDs and EGLNs) (Kaelin and Ratcliffe,
2008; Myllyharju, 2013; Semenza, 2012). In normoxic conditions,
HIF-P4Hs hydroxylate the HIFα subunit, which facilitates binding
of the von Hippel–Lindau (VHL) E3 ubiquitin ligase complex and
results in subsequent proteasomal degradation of HIFα. Under
hypoxic conditions, however, HIF-P4Hs are inhibited allowing
formation of the active HIFαβ heterodimer. Three HIFα isoforms
exist in humans, with HIF1α and HIF2α being the main regulators
of hypoxia target genes with at least partially non-overlapping
functions (Keith et al., 2011; Koh and Powis, 2012; Schödel et al.,
2013).
Reduced oxygen supply and increased HIF signaling is
associated with different pathologies, including fibrosis and
cancer (Higgins et al., 2008; Semenza, 2012). Intratumoral
hypoxia is a common feature of the microenvironment of solid
tumors of different origin, and overexpression of HIF is a sign of
tumors that are highly resistant to chemo- and radiotherapy and
have increased risk of metastasis (Vaupel and Mayer, 2007).
Epithelial–mesenchymal transformation (EMT) is a physiological
event in tissue development and regeneration, but promotes
metastasis of malignant cells and contributes to the pathogenesis
of tissue fibrosis (Higgins et al., 2008; Massagué, 2012; Rankin and
Giaccia, 2016; Ruthenborg et al., 2014). Increased HIF signaling
has been shown to induce EMT in several cell types either
by directly regulating certain key EMT transcription factors or by
indirectly affecting other cell signaling pathways such as, for
example, Notch and transforming growth factor-β (TGFβ) pathways
(Rankin and Giaccia, 2016).
TGFβ signaling can promote tumor growth, invasion and
metastasis, and elevated TGFβ expression correlates with tissue
fibrosis (Arjaans et al., 2012; Higgins et al., 2008;Massagué, 2012).
However, TGFβ also has an opposite physiological role, and it is
required for the maintenance of tissue homeostasis and suppression
of tumor progression and can act as a tumor suppressor in
premalignant cells (Arjaans et al., 2012; Massagué, 2012). The
human TGFβ family includes over 30 members, which can be
divided into two subfamilies: the TGFβ–activin–Nodal subfamily
and the bone morphogenetic protein (BMP) subfamily (Massagué,
2012). TGFβ receptors are heterotetramers consisting of two TGFβ
type I receptors (TGFβR1) and two TGFβ type II receptors
(TGFβR2) (Massagué, 2012). TGFβ type III receptor (TGFβR3),
also known as betaglycan, functions as a coreceptor with the other
members of TGFβ receptor superfamily (Jovanovic ́ et al., 2016).
TGFβ binds to TGFβR2 and recruits TGFβR1, which leads to
TGFβR2-mediated phosphorylation and activation of TGFβR1.
TGFβR1 then phosphorylates receptor-bound Smad transcription
factors (Smad2/3), which form a complex with Smad4 and
translocate to the nucleus, where they regulate the expression of
∼300 target genes (Massagué and Gomis, 2006). TGFβ itself is
secreted from cells as part of a large latent complex that consists of
latency-associated peptide (LAP) and one of the latent TGFβ-
binding proteins (LTBPs) (Robertson and Rifkin, 2013). Therefore,
TGFβ needs to be activated by releasing it from the latent complex
before it can bind its receptor. Active TGFβ can be released from the
latent complex by protease-mediated processing or by integrin-
mediated mechanical disruption of the LAP–TGFβ interaction
(Arjaans et al., 2012).Received 12 September 2017; Accepted 17 April 2018
1Oulu Center for Cell-Matrix Research, Biocenter Oulu, Faculty of Biochemistry and
Molecular Medicine, University of Oulu, 90220 Oulu, Finland. 2Department of
Surgery (Section of Research), University of Chicago, Chicago, IL 60637-1470, USA.
*Present address: Developmental Biology Program, Institute of Biotechnology,
University of Helsinki, 00014 Helsinki, Finland.
‡These authors contributed equally to this work
§Author for correspondence ( johanna.myllyharju@oulu.fi)
K.S.M., 0000-0002-1251-0580; J.V.M., 0000-0003-1009-8059; A.M., 0000-0002-
6263-8101; J.M., 0000-0001-7772-1250
1













HIF and Smad-binding sites are frequently found close to each
other in the regulatory regions of the target genes, suggesting a
possible cooperative gene regulation by hypoxia and TGFβ
signaling (Ruthenborg et al., 2014). Whether hypoxia and HIF-
mediated signaling regulate epithelial cell polarity has not been
thoroughly addressed. Here, we have studied this by using a well-
characterized three-dimensional (3D) Madin–Darby canine kidney
(MDCK) epithelial cell culture system, and show that HIF1
promotes TGFβ signaling, which, in turn, disrupts the formation
of polarized MDCK cysts. Furthermore, we identify BAMBI as a
novel mediator of HIF1-driven activation of TGFβ signaling and
show that inactivation of BAMBI rescues MDCK cystogenesis
during hypoxia.
RESULTS
Morphogenesis of MDCK cysts is perturbed during hypoxia in
a HIF1α-dependent manner
To study the role of HIF1α in the cystogenesis of MDCK cells, we
generated three independent HIF1α-knockdown (KD) MDCK cell
lines by using a retrovirus-mediated RNA interference (RNAi)
methodology (Manninen et al., 2005; Schuck et al., 2004). Efficient
silencing, ranging from 65% to 95%, of the target HIF1α (HIF1A)
mRNA was confirmed by quantitative real-time PCR (qRT-PCR)
(Fig. 1A; Table S1). In accordance with the HIF1α mRNA
depletion, the HIF1α protein level was reduced in the HIF1α-KD
cell lines under hypoxic conditions when compared with wild-type
(WT) control cells (Fig. 1A,B). All following experiments were
Fig. 1. Hypoxia leads to disrupted morphogenesis of MDCK cysts. (A–C) Control and three independent HIF1α-KD (#1, #2 and #3) MDCK cell lines were
grown in 2D in normoxic (N) and hypoxic (H, 24 h 1% O2) conditions. (A) Expression of HIF1αmRNA in normoxia was analyzed by qRT-PCR analysis. Data are
presented as mean±s.d., n=11. A quantification of the HIF1α protein amount during hypoxia, from experiments as shown in B, is also shown, n=3. (B) A
representative HIF1α western blot of control and the HIF1α-KD MDCK cell lines. α-tubulin is shown as a loading control. (C) qRT-PCR analysis of the mRNA
expression level of selected HIF target genes in 2D cultures of control and the HIF1α-KD#3 cell lines under normoxic (N) and hypoxic (H, 24 h 1%O2) conditions.
The hypoxia-induced fold change in the mRNA expression level is shown. Data are presented as mean±s.d., n≥6. (D) Control and HIF1α-KD MDCK cysts were
grown in 3D under normoxic or hypoxic (1% O2) conditions. At day 6 the cysts were fixed and stained for the apical membrane marker podocalyxin (green), actin
(phalloidin, red) and nuclei (DAPI; blue). A single confocal slice from themiddle of the cysts is shown. Scale bars: 20 µm. (E) Quantification of the cyst phenotypes
in control and HIF1α-KD MDCK cell lines grown as in D. The percentage of cysts with a single lumen were calculated and averaged from 4–8 independent
experiments. A minimum of 160 cysts per sample was scored in each experiment. Data are presented as mean±s.d., n≥4. *P<0.05; **P<0.001; ***P<0.0001; ns,
not significant (Student’s t-test for pairwise comparisons).
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performed using HIF1α-KD clone #3, which had the highest (95%
at mRNA level) silencing. Similar data were obtained with the other
two clones, with the penetrance of the phenotype correlating with
the knockdown efficiency (as shown for clone #1 in Fig. 1E).
MDCK cells infected with a retrovirus containing an empty short
hairpin RNA (shRNA) expression cassette were used as a control in
all experiments.
To examine the hypoxia response in WT and HIF1α-KD MDCK
cells, we performed a qRT-PCR analysis of selected knownHIF target
genes. Whereas the WT cells responded to hypoxia (1% O2, 24 h) by
upregulation of the mRNA levels of adrenomedullin (ADM), aldolase
C fructose-bisphosphate (ALDOC), BCL2/adenovirus E1B (BNIP3),
BCL2/adenovirus E1B 19 kDa interacting protein 3-like (BNIP3L),
vascular endothelial growth factor A (VEGFA) and lysyl oxidase
(LOX), HIF1α-KD cells failed to efficiently induce these target genes
(Fig. 1C). It should be noted that the extent of hypoxic induction of a
particular gene depends on the cell type and experimental conditions;
the range in the case of the MDCK cells in our experimental setup
being from∼2-fold (LOX) to∼20-fold (ADM) induction. Irrespective
of the magnitude of the hypoxic induction, knockdown of HIF1α
reduced it in a statistically significant manner.
Next, we studied the effects of hypoxia on epithelial
morphogenesis by culturing the WT and HIF1α-KD MDCK cells
in 3D basement membrane extract (BME) gels, where they form
hollow cysts lined by one layer of polarized cells under normal
conditions (Myllymäki et al., 2011). All cultures were initially
grown in normoxic conditions for 1 h, after which half of the
cultures were transferred to hypoxia (1% O2) and cultured for
6 days. During normoxia, ∼80% of the WT MDCK cells formed
hollow spherical cysts with the apical surface of the epithelial cells
lining the lumen (hereafter denoted as the regular cyst phenotype) as
determined by podocalyxin staining (Fig. 1D,E). The apical
membrane also stained strongly with phalloidin, indicating
formation of actin-rich microvilli (Fig. 1D). In contrast, under
hypoxic conditions most of the WT MDCK cysts lacked a central
organized lumen, displayed an irregular podocalyxin staining
pattern and the most intense actin staining at the basal surface
facing the BME gel (Fig. 1D,E). Interestingly, the vast majority of
the HIF1α-KD cysts were of regular phenotype in both normoxic
(76.5%) and hypoxic (74%) conditions (Fig. 1D,E).
HIF1α modulates EMT and TGFβ signaling pathways under
hypoxic conditions
To screen for potential signaling pathways involved in the hypoxia-
induced morphogenetic changes in wild-type MDCK cells in 3D
BME gels (Fig. 1D), we performed microarray-based gene
expression analysis in WT and HIF1α-KD MDCK cells grown
under normoxic and hypoxic conditions for 6 days. The microarray
analysis suggested that there were changes in the expression of a
number of genes associated with EMT and TGFβ signaling
pathways between the WT and HIF1α-KD MDCK cells during
hypoxia (results deposited in the Gene Expression Omnibus
database under accession number GSE94772).
EMT is regulated by a complex network of transcription factors,
such as the Snail family zinc finger 1 and 2 (SNAI1 and SNAI2) and
the zinc finger E-box-binding homeobox 1 (ZEB1) (Kalluri and
Weinberg, 2009). Downregulation of E-cadherin and upregulation of
vimentin are two well-documented indications of EMT, and the
expression levels of these proteins can be regulated at both
transcriptional and post-translational level (Kalluri and Weinberg,
2009). Culture of theMDCK cells in hypoxic conditions led to a∼2–
3-fold induction of the SNAI1 and SNAI2 mRNAs, whereas no
hypoxia-inducibility of ZEB1, E-cadherin and vimentin mRNAs was
observed (Fig. 2A). No systematic effect of the HIF1α-KD on the
mRNA expression of these EMT markers was observed during
hypoxia (Fig. 2A). Expression of E-cadherin protein (Fig. 2B,C) was
in linewith the observedmRNA levels (Fig. 2A). The relative amount
of vimentin protein was increased by ∼5-fold in hypoxic versus
normoxic conditions in WT cells, while in HIF1α-KD cells, this
hypoxic induction was significantly reduced (Fig. 2C,D). Despite
these observed effects and the abnormal cystogenesis in hypoxic
MDCK cells (Fig. 1C,D), the tight junction marker ZO-1 displayed
restricted subapical localization around small lumens inmultilumenal
hypoxic MDCK cysts, which remained as tight epithelial clusters and
did not display invasive mesenchymal morphology (Fig. S1A).
EMT is a multistep process where TGFβ signaling is known to
regulate the transition between epithelial and mesenchymal state
(Kalluri and Weinberg, 2009). During hypoxia, the mRNA
expression levels of the studied TGFβ ligands, receptors and
effectors were systematically downregulated in HIF1α-KD cells
when compared with WT cells, with the exception of TGFβ3 and
TGFβR2 (Fig. 2E). In line with this, microarray analysis showed
downregulation of multiple TGFβ target genes, such as for example
CDKN1A, COL1A1, COL1A2, COL3A1 and IGF1 in the HIF1α-
KD cells. However, PAI1 (also known as SERPINE1), a commonly
used marker for TGFβ pathway activation was significantly
upregulated in hypoxic HIF1α-KD cells according to the
microarray analysis. It should be noted that PAI1 is a well-known
HIF2 target (Geis et al., 2015; Meade et al., 2007; Suzuki et al.,
2014), which is likely to explain this effect. qRT-PCR analysis
shown for CDKN1A, CDC25A and PAI1 (Fig. 2E) was in line with
the microarray data analysis. Given that it is common that there are
post-translational regulatory mechanisms for growth factor
receptors, we also analyzed the TGFβR1 and TGFβR2 protein
levels. Both of these receptors were downregulated at protein level
in hypoxic HIF1α-KD cells (Fig. 2G–J). TGFβR1 colocalized with
the tight junction protein marker zonula occludens 1 (ZO-1) in both
2D and 3D MDCK cultures, and HIF1α-KD or hypoxia did not
affect the localization (Fig. S2A,B). These data suggest that HIF1α-
KD affects the TGFβ signaling cascade.
TGFβ signaling is required for hypoxia-induced loss of cyst
polarization
Given the observed HIF1α-dependent modulation of the TGFβ
pathway, we next wanted to address whether activation of TGFβ
signaling mediates the hypoxia-induced perturbation of cyst
formation. To this end, WT and HIF1α-KD cells were seeded into
3DBME gels and subjected to normoxic or hypoxic conditions in the
presence of SB431542, an inhibitor of TGFβR1, or in the presence of
recombinant active TGFβ1 (Fig. 3A,B). Addition of SB431542 to
WT MDCK cell cultures did not interfere with cyst polarization
during normoxia but partially rescued central lumen formation under
hypoxic conditions, while SB431542 did not affect cystogenesis of
the HIF1α-KD cells (Fig. 3A,B). Upon addition of recombinant
active TGFβ1, cystogenesis was severely disturbed in both WT and
HIF1α-KD MDCK cells during normoxia and hypoxia (Fig. 3A,B).
These functional data suggest that hypoxia-mediated stabilization of
HIF1α disrupts polarized morphogenesis in a TGFβ-signaling-
dependent manner. Because addition of active TGFβ bypasses
HIF1α-KD induced effects on polarity, it seems likely that HIF1α
regulates an early step in hypoxia-driven TGFβ activation, possibly
expression or activation of the latent TGFβ and TGFβR complexes.
Smads are central players in the TGFβ signaling pathway,
operating downstream of the TGFβR engagement (Massagué and
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Gomis, 2006). In order to confirm the involvement of TGFβ
pathway in the disruption of hypoxic cystogenesis, we studied the
kinetics of Smad2 phosphorylation in WT and HIF1α-KD MDCK
cells upon exposure to hypoxic conditions for different time
periods (Fig. 3C,D). The total Smad2 protein level remained
constant in WT cells during the 24 h incubation in hypoxic
conditions, whereas phosphorylation of Smad2 (pSmad2)
increased strongly, peaking at 18 h (Fig. 3C,D). In contrast,
HIF1α-KD abolished such a peak in Smad2 phosphorylation
during hypoxia (Fig. 3C,D,F).
Fig. 2. Expression of genes involved in EMT and TGFβ pathways are deregulated in hypoxia. qRT-PCR analysis of the expression of mRNA encoding
(A) SNAI1, SNAI2, ZEB1, E-cadherin and Vimentin, and (F) Smad2, Smad3, Smad4, TGFβ1, TGFβ2, TGFβ3, TGFβR1, TGFβR2, TGFβR3, CDKN1A,
CDC25A and PAI1 in control and HIF1α-KD#3 cell lines cultured in 2D in normoxic (N) and hypoxic (H, 24 h 1%O2) conditions. Data are presented asmean±s.d.,
n≥4, of relative expression levels with respect to those in normoxic control cells. (B–J) Western blot analysis of (B) E-cadherin, (D) Vimentin, (G) TGFβR1
and (I) TGFβR2 in control and HIF1α-KD#3 cell lines cultured in 2D in normoxic (N) and hypoxic (H, 24 h 1% O2) conditions. α-tubulin is shown as a loading
control. Quantifications of western blot data of (C) E-cadherin, (E) vimentin, (H) TGFβR1 and (J) TGFβR2 protein levels. Data are presented asmean±s.d. (n=4) of
relative expression levels with respect to those in normoxic controls. *P<0.05; **P<0.001; ***P<0.0001; ns, not significant (Student’s t-test for pairwise
comparisons). AU, arbitrary units.
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Fig. 3. Activated TGFβ signaling disrupts cyst polarization during hypoxia. (A) Control and HIF1α-KD MDCK cysts were grown in 3D BME gels under
normoxic (N) or hypoxic (H, 1%O2) conditionswith andwithout recombinant human TGFβ, and with andwithout inhibitor SB431542 being added, as indicated (on
the second and fourth days of culture). At day 6 the cysts were fixed and stained for an apical membranemarker podocalyxin (green), actin (red) and nuclei (DAPI,
blue). A single confocal slice from the middle of the cysts is shown. Scale bars: 20 µm. (B) Quantification of the cyst phenotypes in control and HIF1α-KD MDCK
cells grown as in A. The percentage of cysts with a single lumen was calculated and averaged from 4–6 independent experiments. A minimum of 160 cysts per
sample was scored in each experiment. Data is presented as mean±s.d. (n=3). (C) Western blot analysis of Smad2, pSmad2 and HIF1α protein levels in control
and HIF1α-KD cells cultured in 2D under normoxic (N) or hypoxic (H, 1% O2) conditions for 1, 3, 6, 12, 18 and 24 h. α-tubulin is shown as a loading control.
Quantification of this blot is shown in (D) for Smad2 and pSmad2, and in (E) for HIF1α protein. (F,G) Control and MDCK cells were cultured in 2D under normoxic
(N) or hypoxic (H) conditions for 18 h followed by lysis and western blot analysis of (F) Smad2 and pSmad2 levels or (G) HIF1α protein levels. For Smad2 and
pSmad2 quantification, the data are presented as mean±s.d. (n=3) of relative expression with respect to Smad2 expression in normoxic control cells, and for
HIF1α quantification, data is presented as mean±s.d. (n=3) relative to HIF1α expression in normoxic control cells. *P<0.05; **P<0.001; ns, not significant
(Student’s t-test for pairwise comparisons). AU, arbitrary units.
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TGFβ is secreted as a large latent complex and must be activated
before it can bind to the TGFβR complex to trigger signaling. Given
the known role of αV integrins in the activation of latent TGFβ
(Arjaans et al., 2012), we studied whether αV integrin (ItgαV)
function is necessary for the hypoxia-induced loss of polarity. We
cultured ItgαV-KDMDCK cells (Teräväinen et al., 2013) for 6 days
in 3D BME gels under normoxic and hypoxic conditions. Depletion
of αV integrin did not disturb cystogenesis during normoxia, as
∼75% of the WT MDCK cells and ∼72% of the ItgαV-KDMDCK
cells formed polarized cysts with a hollow lumen during the 6 day
culture in normoxic conditions (Fig. 4A,B). Remarkably, while the
majority (73%) of WT cells failed to form polarized cysts with a
lumen during hypoxia, more than half (56%) of ItgαV-KD cysts
displayed polarized central lumens under these conditions
(Fig. 4A,B). Moreover, a tendency towards lower levels of total
secreted TGFβ and a statistically significant reduction in the levels
of active TGFβ was observed in ItgαV-KD cells when compared to
WT cells (Fig. 4C,D). This data shows that αV integrins are required
for the hypoxia-induced loss of polarity, presumably because of
their important role in the activation of latent TGFβ.
We next measured the amount of total and active TGFβ1 in the
culture medium of hypoxic WT and HIF1α-KD MDCK cells. The
HIF1α-KD cells displayed a significantly lower amount of both
total and active secreted TGFβ relative to WT cells (Fig. 5A).
Furthermore, we analyzed the mRNA and protein levels of latent
TGFβ-binding protein 1 (LTBP1) and the data showed that both the
Fig. 4. Knockdown of ItgαV rescues cyst
polarization in hypoxia. (A) Control and ItgαV-KD
MDCK cysts were grown in 3D BME gels under
normoxic or hypoxic (1% O2) conditions. At day 6, the
cysts were fixed and stained for the apical membrane
marker podocalyxin (green), actin (red) and nuclei
(DAPI, blue). A single confocal slice from the middle of
the cysts is shown. Scale bars: 20 µm. (B)
Quantification of the cyst phenotypes in control and
ItgαV-KD MDCK cell lines grown as in A. N, normoxic
conditions; H, hypoxic conditions. The percentage of
cysts with a single lumen (black), or with a poorly
formed or no lumen (white) was calculated and
averaged from 4–8 independent experiments. Data is
presented asmean±s.d. (n=3). Aminimum of 160 cysts
per sample was scored in each experiment. (C) Total
and (D) active TGFβ-levels were measured from
conditioned medium from control and ItgαV-KD MDCK
cells cultured in 2D in normoxia. Data is presented as
mean±s.d. (n=3). *P<0.05; ***P<0.0001; ns, not
significant (Student’s t-test for pairwise comparisons).
AU, arbitrary units.
Fig. 5. Knockdown of HIF1α decreases secretion and
activation of TGFβ. (A) The total (latent and active) and active
TGFβ1 amount in conditioned medium from of control and
HIF1α-KD MDCK cell lines cultured in hypoxia (24 h 1% O2) in
2D. Data are presented as mean±s.d., n=3. (B) qRT-PCR and
(C,D) Western blot analysis of LTBP1 mRNA and protein
expression levels in control and HIF1α KD#3 cell lines cultured
in 2D in normoxia (N) and hypoxia (H, 6 days 1% O2). Data in B
is presented as mean±s.d. (n=3) of relative expression levels
with respect to those in normoxic control cells; data in D is
presented as mean±s.d. (n=3) of protein expression levels in
normoxia and hypoxia, α-tubulin was used as a loading control.
*P<0.05; **P<0.001; ***P<0.0001; ns, not significant (Student’s
t-test for pairwise comparisons). AU, arbitrary units.
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mRNA and protein level of LTBP1 was downregulated in HIF1α-
KD MDCK cells under hypoxic conditions when compared with
WT cells (Fig. 5B–D).
Taken together, the above data shows that the hypoxia-mediated
stabilization of HIF1α is required for efficient activation of TGFβ
signaling, which in turn leads to disruption of the polarized lumen
formation in MDCK cells. Moreover, HIF1α is likely to operate
upstream of TGFβR activation, because addition of recombinant
active TGFβ1 readily disrupts cystogenesis during normoxia and
hypoxia irrespective of the HIF1α status (Fig. 3A,B).
Polarized cysts are resistant to hypoxia-induced
morphological changes
It has been reported that most of the critical events of lumen
formation in 3D BME gel-embedded MDCK cells occur during the
first 24 h when individual cells divide and form small cell clusters
(Bryant et al., 2010). Upon initial polarization, the polarized
organization of cysts with an enclosed central lumen is maintained
by continuous subapical tight junctions, which seal the lumen from
the basolateral side, and via precisely oriented cell divisions. In our
experiments, when MDCK cells were transferred to hypoxic
conditions, stabilization of HIF1α protein was observed 3–12 h
after the transfer (Fig. 3C,E,G) and, based on Smad2
phosphorylation, the TGFβ pathway was activated maximally 18–
24 h after (Fig. 3C,D,F). To study what is the critical timeframe
when hypoxia affects the polarization, we culturedWTMDCK cells
in normoxic conditions for 24 h or 5 days after which they were
exposed to hypoxia for 5 days and 24 h, respectively, and vice versa,
with the cultures being started in hypoxic conditions. The number of
cysts with polarized central lumens, ∼70%, formed by cells that
were first cultured in normoxic conditions for 24 h or 5 days
followed by hypoxia, was only slightly lower than in the cells
cultured continuously in normoxic conditions for 6 days (78%)
(Fig. 6). In the opposite setup, when the cells were exposed to
hypoxia for the first 24 h or 5 days followed by normoxia, ∼40–
50% of the cysts had normal lumens, being slightly higher than in
the cells cultured continuously in hypoxic conditions for 6 days
(32%) (Fig. 6). These data indicate that the oxygenation status is
critical for the establishment of polarity within the first 24 h, while
polarized cysts are quite resistant to hypoxia-induced
morphological changes. Interestingly, our data also indicate that
the cellular effects caused by exposure to hypoxia during the early
stage of cystogenesis when cells are still non-polarized, are
maintained (for a prolonged time) even after the cells have been
returned to normoxic conditions.
Inactivation of BAMBI restores polarized morphogenesis
during hypoxia
In order to characterize the key HIF1α target genes regulating TGFβ
signaling, we looked into the microarray data for the most efficiently
downregulated hypoxia-responsive genes in the HIF1α-depleted
cells. One such candidate gene was BMP and activin membrane-
bound inhibitor (BAMBI), which has been previously implicated in
the regulation of BMP/activin/TGFβ signaling (Onichtchouk et al.,
1999; Tsang et al., 2000). BAMBI is structurally related to the type I
receptors of the TGFβ family, but it lacks a functional serine/
threonine kinase domain and is generally thought to function as an
inhibitory pseudoreceptor for TGFβ/BMP signaling pathways, but
opposing effects have also been reported (Gonzales et al., 2010;
Massagué et al., 2005; Sasaki et al., 2004; Zhang et al., 2016). qRT-
PCR analysis confirmed hypoxia-dependent upregulation of BAMBI
mRNA in WT but not in HIF1α-KD MDCK cells (Fig. 7A). The
BAMBI mRNA expression level was also robustly downregulated in
normoxic HIF1α-KD relative to WT cells (Fig. 7A). This is not
unexpected, as accumulating evidence indicates that HIF1 has
important roles even during normoxia although being present at a low
level (Bárdos and Ashcroft, 2005; Sakamoto et al., 2014). To study
the functional role of BAMBI inMDCKcells, we designed two guide
RNA (gRNA) constructs targeting canine BAMBI (Table S2) and
Fig. 6. Polarized cysts are resistant to hypoxia-induced morphological
changes. (A) Control and HIF1α-KD MDCK cysts were grown in 3D BME gels
under normoxic (N) or hypoxic (H, 1% O2) conditions using different time
regimes as indicated on the left of the panels. At day 6, the cysts were fixed and
stained for the apical membrane marker podocalyxin (green), actin (red) and
nuclei (DAPI, blue). A single confocal slice from the middle of the cysts is
shown. Scale bars: 20 µm. (B) Quantification of the cyst phenotypes in control
and HIF1α-KD MDCK cell lines grown as in A. The percentage of cysts with a
single lumen were calculated and averaged from eight independent
experiments. A minimum of 160 cysts per sample was scored in each
experiment. Data are presented as mean±s.d., n≥4. *P<0.05; **P<0.001;
***P<0.0001; ns, not significant (Student’s t-test for pairwise comparisons).
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Fig. 7. Knockout of BAMBI rescues cyst polarization in hypoxia. (A) qRT-PCR analysis of BAMBI mRNA expression in control and HIF1α-KD#3 cell lines
cultured in 2D in normoxic (N) and hypoxic (H, 24 h 1% O2) conditions. Data are presented as mean±s.d., n=3. (B) Control and BAMBI-KO MDCK cysts were
grown in 3D BME gels under normoxic or hypoxic (1% O2) conditions. At day 6, the cysts were fixed and stained for the apical membrane marker podocalyxin
(green), actin (red) and nuclei (DAPI, blue). A single confocal slice from the middle of the cysts is shown. Scale bars: 20 µm. (C) Quantification of the cyst
phenotypes in control and BAMBI-KO MDCK cell lines grown as in B. The percentage of cysts with single lumen was calculated and averaged from three
independent experiments for each of the two subclonal cell lines. A minimum of 160 cysts per sample was scored in each experiment. Data are presented as
mean±s.d., n=6 (three independent analyses of the two subclonal cell lines). (D) Total (latent and active) and active TGFβ1 amount in conditioned media of
control and BAMBI-KO MDCK cell lines cultured in 2D in hypoxia (24 h 1% O2). Data are presented as mean±s.d., n=6 (three independent analyses of the
two subclonal cell lines), ***P<0.0001 (Student’s t-test for pairwise comparison). (E) Control and BAMBI-KO MDCK cysts were grown in 3D BME gels under
normoxic (N) or hypoxic (H, 1% O2) conditions with and without recombinant human TGFβ, and with and without inhibitor SB431542 being added, as indicated
(on the second and fourth days of culture). At day 6, the cysts were fixed and stained for the apical membrane marker podocalyxin (green), actin (red) and
nuclei (DAPI, blue). A single confocal slice from the middle of the cysts is shown. Scale bars: 20 µm. (F) Quantification of the control and BAMBI-KO cyst
phenotypes grown as in A. The percentage of cysts with single lumen was calculated and averaged from three independent experiments for each of the two
subclonal cell lines. A minimum of 160 cysts per sample was scored in each experiment. Data are presented as mean±s.d. *P<0.05; **P<0.001; ***P<0.0001; ns,
not significant (Student’s t-test for pairwise comparisons). AU, arbitrary units.
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generated two independent BAMBI-KO clones (Table S3) by using
the lentiCRISPR methodology (Ran et al., 2013). Successful editing
of both alleles in the first exon leading to premature stop codon was
confirmed by sequencing (Table S3). MDCK cells infected with non-
targeting lentiCRISPR virus were used as a control in all experiments.
Control and BAMBI-KO MDCK cells were seeded into 3D BME
gels and grown in normoxic and hypoxic conditions. During
normoxia, the control cells efficiently formed hollow cysts with a
polarized lumen (91%), while, during hypoxia, a polarized central
lumen was formed in only 36% of the cysts (Fig. 7B,C). Interestingly,
the majority of BAMBI-KO MDCK cells formed polarized cysts
under both normoxia (84%) and hypoxia (67%) (Fig. 7B,C).
HIF1-dependent activation of TGFβ signaling was herein found
to be essential for hypoxia-induced disruption of cystogenesis
Fig. 8. BAMBI expression is required for hypoxia-induced activation of TGFβ signaling in MDCK cells. (A) Western blot analysis of Smad2 and pSmad2 in
control and in BAMBI-KO cells cultured in 2D in normoxic conditions (N) or in hypoxic (H) conditions for 24 h. α-tubulin is shown as a loading control. (B)
Quantification of Smad2 and pSmad2 protein levels. Data is presented as mean±s.d., n=8 (four independent experiments for each of the two subclonal cell lines),
of the ratio of protein expression level in hypoxia relative to normoxia. (C) qRT-PCR analysis of mRNA expression levels of TGFβ signaling-related genes
(encoding Smad2, Smad3, Smad4, TGFβ1, TGFβ2, TGFβ3, TGFβR1, TGFβR2, TGFβR3, LTBP1, CDKN1A, CDC25A and PAI1) in control and BAMBI-KO cells in
2D in normoxic and hypoxic (24 h, 1% O2) conditions. Data are presented as mean±s.d., n≥6 (at least three independent experiments for each of the two
subclonal cell lines), of relative expression levels with respect to those in normoxic control cells. *P<0.05; **P<0.001; ***P<0.0001; ns, not significant (Student’s t-
test for pairwise comparisons). AU, arbitrary units.
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(Fig. 3). To see whether BAMBI operates on this same pathway, we
first measured the amount of total and active TGFβ1 in the culture
medium of hypoxic WT and BAMBI-KO MDCK cells. The
BAMBI-KO cells displayed a significantly lower amount of total
secreted TGFβ and a tendency (although not statistically significant)
to a reduced amount of activated TGFβ in comparison to WT
(Fig. 7D). Next, we cultured WT and BAMBI-KO cells in 3D and
treated them with recombinant TGFβ and/or TGFβR1 inhibitor
(SB431542). Similar to what was found in HIF1α-KD cells,
addition of TGFβ1 into BAMBI-KO cultures had perturbed
cystogenesis both under normoxic and hypoxic conditions,
whereas treatment with SB431542 led to modest improvement in
the polarization of WT, but not of BAMBI-KO, cysts during
hypoxia (Fig. 7E,F). Importantly, Smad2 phosphorylation was
clearly inhibited in BAMBI-KO cells indicating that, in addition to
HIF1α, expression of BAMBI is required for hypoxia-induced
activation of TGFβ signaling inMDCK cells (Fig. 8A,B). qRT-PCR
analysis of the key genes in the TGFβ pathway revealed that
BAMBI expression significantly contributed to hypoxia-driven
induction of genes encoding TGFβ1, Smad2, Smad4, TGFβR3,
LTBP1, CDKN1A and CDC25A (Fig. 8C). Similar to HIF1α-KD
MDCK cells (Fig. 2E), BAMBI-KO MDCK cells had an elevated
expression level of PAI1 during hypoxia (Fig. 8C).
DISCUSSION
In the present work, we show that hypoxia interferes with epithelial
apical-basal polarization by promoting activation of the TGFβ
pathway in a HIF1α-dependent manner. We identified BAMBI as a
novel HIF-regulated gene that was required for hypoxia-induced
activation of TGFβ signaling leading to loss of cyst polarity. TGFβ
pathway is a well-known regulator of EMT in several epithelial
cell types and hypoxia is also known to contribute to EMT.
Hypoxia appears to enhance TGFβ-driven signaling although the
mechanistic details are somewhat unclear. Hypoxia upregulates
Smad3 expression and HIF1α has been shown to interact with the
HIF-responsive elements (HREs) located in the TGFβ1 and TGFβ3
promoter regions (Breitkopf et al., 2006; Hung et al., 2013;
Sánchez-Elsner et al., 2001; Schäffer et al., 2003). Here, we found
that HIF1α depletion suppressed hypoxia-induced upregulation of
Smad3 and several TGFβ pathway-related genes. In line with these
findings, HIF1α-KD MDCK cells also secreted less TGFβ,
produced reduced levels of LTBP1 and failed to induce Smad2
phosphorylation upon exposure to hypoxia.
Importantly, we demonstrate that the hypoxia-induced loss of
polarity was dependent on TGFβ signaling downstream of HIF1α
function. Whereas HIF1α expression peaked 3 h after exposure to
hypoxia, robust Smad2 phosphorylation was observedmuch later, at
18 h post hypoxia. TGFβ is secreted from cells as a large latent
complex that associates with extracellular matrix, and can
be mechanically activated by integrins, αV integrins being
particularly important in this process (Annes et al., 2004; Wipff
and Hinz, 2008). In line with this, inhibition of αV integrin
expression also prevented HIF1α-mediated effects on epithelial
polarity.
EMT-associated phenotypic changes can be facilitated by many
different pathways. Notch signaling has been proposed to synergize
with the TGFβ- and hypoxia-response pathways to induce EMT, and
HIF1α has been shown to directly interact with the intracellular
domain of Notch (Gonzalez and Medici, 2014; Jiang et al., 2011;
Poellinger and Lendahl, 2008). Notch directly upregulates SNAI1
and has been shown to be required for hypoxia-induced
upregulation of SNAI1 and SNAI2 (Chen et al., 2010; Sahlgren
et al., 2008). However, while hypoxia-induced SNAI2 expression
was slightly less prominent in HIF1α-KD MDCK cells in our
experiments, the expression level of SNAI1mRNAwas even higher
in hypoxic HIF1α-KD cells when compared to control cells.
Therefore, further studies are needed to clarify whether
Notch signaling contributes to disruption of polarity in HIF1α-
KD cells.
We identified BAMBI as a hypoxia-inducible gene that was
drastically downregulated in HIF1α-KD MDCK cells, and its
inactivation rescued epithelial cell polarization during hypoxia.
BAMBI is a transmembrane protein that structurally resembles the
TGFβR1 and BMPR1 (Onichtchouk et al., 1999). However, it lacks
the cytoplasmic kinase domain and is therefore generally thought to
function as a negative regulator of both TGFβ and BMP signaling
(Guillot et al., 2012; Tsang et al., 2000). In line with this, depletion
of BAMBI expression reportedly enhances the TGFβ signaling
response in cancer cell lines (He et al., 2016; Marwitz et al., 2016).
Contrary data have also been reported, however, as high levels of
BAMBI expression have been correlated with increased plasma
TGF-β1 levels in chronic obstructive pulmonary disease patients
(Zhang et al., 2016). Here, we found that BAMBI expression was
strongly downregulated in HIF1α-depleted cells in which TGFβ
signaling was inhibited. Bioinformatic analysis identified 24
putative HREs near the promoter region of the canine BAMBI
gene, two of which are conserved in the human BAMBI gene (data
not shown). Depletion of BAMBI expression restored polarization
in hypoxic conditions, and BAMBI was found to contribute to the
activation of the TGFβ pathway in hypoxic MDCK cells. Similar to
HIF1α-KD cells, BAMBI-KO cells modulated the expression of
some of the key genes in the TGFβ pathway and BAMBI-KO cells
failed to efficiently induce Smad2 phosphorylation upon exposure
to hypoxia. While many of the target genes, such as those encoding
TGFβ1, LTBP1, TGFβR3, Smad2 and Smad4, were regulated in
both the HIF1α-KD cells and BAMBI-KO cells, there were also
differences suggesting that although BAMBI clearly regulated
hypoxia-induced loss of cyst polarity, not all of the effects of HIF1α
are mediated by BAMBI. BAMBI is identified here as a novel
HIF1α-regulated protein that plays an important role during




MDCKstrain II cells (ATCC:CCL-34)were used in this study. For 2D and 3D
culture, cells were grown as described previously (Friedrichs et al., 2007;
Myllymäki et al., 2011). MDCK cells were cultured either in normoxic or
hypoxic (1%O2, 5%CO2 and 94%N2) conditions in an Invivo2 400 hypoxic
workstation (Baker Ruskinn, Sanford, ME). The cells were regularly tested,
every 6 months, for mycoplasma contamination.
Generation of HIF1α-KD cells by retrovirus-mediated RNA
interference
HIF1α-KD cell lines were generated by infection of MDCK cells with
retroviruses coding for shRNA constructs, and selection of infected cells
was achieved with puromycin as previously described (Myllymäki et al.,
2011). Three targeting sequences were cloned into the RVH1-puro vector
and their efficiencies to silence HIF1α expression in MDCK cells were
determined by qRT-PCR (Table S1).
Generation of BAMBI-KO cells by lentivirus-mediated expression
of sgRNAs and Cas9
Gene editing with lentivirus-mediated co-expression of Cas9 and single-
guide RNA (sgRNA) constructs was performed as previously described
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(Shalem et al., 2014) with some modifications. The first exon of the
canine BAMBI was used as a template for gRNA design. Target
sequences with no off target sites with less than three mismatches in
the canine genome database (European Nucleotide Archive), were
selected based on the FASTA similarity search-tool (EMBL-EBI). Two
targeting sequences were selected and the corresponding gRNA
oligonucleotides with BsmBI overhangs (Sigma-Aldrich, St Louis,
MO) were subcloned into lentiCRISPRv1 (Table S2). Production of
lentivirus and transfection were performed as described previously
(Shalem et al., 2014). Puromycin-resistant cells were subcloned by
fluorescence-activated cell sorting. Subclonal cell lines were generated
and sequenced as described previously (Shalem et al., 2014), and two
subclonal cell lines generated from the two gRNA constructs,
BAMBIKO#1 and BAMBIKO#2, respectively, were used as biological
replicates (Table S3).
Reagents
Recombinant human TGFβ1 (100-21, PeproTech, Stockholm, Sweden) was
reconstituted in 10 mM citric acid pH 3.0, at a final stock concentration of
1 µg/ml according to the manufacturer’s protocol, and stored at −20°C.
SB431542 (1614, Tocris Bioscience, Bristol, UK), a selective inhibitor of
TGFβR1 was stored at a concentration of 5 µM in dimethyl sulfoxide
(DMSO) at −20°C.
Immunostaining
For immunostaining, 3D MDCK cells in 30 µl blobs of Cultrex® 3D Culture
Matrix™ BME (3445-005-01, Trevigen, Gaithesburg, MD) were cultured in
normoxic or hypoxic conditions for 6 days. For immunostaining with anti-
podocalyxin antibody (3F2/D8 cell line, Developmental Studies Hybridoma
Bank, Iowa City, IA), anti-E-cadherin antibody (rr1, 1:100, Developmental
StudiesHybridomaBank) and anti-ZO-1 antibody (339100, 1:200, Invitrogen,
Carlsbad, CA), MDCK cells in Cultrex blobs were fixed with 4%
paraformaldehyde in phosphate-buffered saline (PBS) for 20 min, followed
by quenching with 200 mM glycine in PBS for 20 min, and permeabilization
and blocking with 0.1% Triton X-100 and 0.5% bovine serum albumin (BSA)
in PBS for 1 h. All steps were performed at room temperature (RT). For
immunostaining of TGFβR1 (ab31013, 1:200, Abcam, Cambridge, UK) and
ZO-1 (339100, 1:200, Invitrogen), 2D MDCK cells were fixed with ice-cold
methanol for 20 min at 4°C, followed by blocking with 0.5% BSA in PBS for
1 h. Primary antibodies were added in corresponding blocking solutions and
incubated overnight at 4°C. Corresponding secondary antibodies, phalloidin
(ab176757, 1:2000, Abcam, Cambridge, UK), for actin staining, and DAPI
(D9542, 1:500, Sigma-Aldrich), for DNA staining, were added and incubated
overnight at 4°C.
Microarray analysis
2D MDCK cells were seeded at a density of 2.0×105 cells in 3.5-cm
diameter dishes, cultured in normoxic conditions for 24 h and then
transferred into hypoxic conditions for 24 h. Total RNAwas isolated using
an RNeasy Kit (Qiagen, Hilden, Germany) according to the manufacturer’s
protocol. The total RNAwas reverse transcribed into cDNA by using an 3′
IVT Express Kit (Affymetrix, Santa Clara, CA), hybridized with the
GeneChip Canine Genome 2.0 Array plates according to manufacturer’s
instructions (https://assets.thermofisher.com/TFS-Assets/LSG/manuals/
expression_analysis_technical_manual.pdf ) and the GeneChips were
scanned with an Affymetrix gene chip scanner 3000 7G according to the
manufacturer’s protocol in Biocenter Oulu DNA Analysis Core Facility.
Affymetrix CEL files (Gene Expression Omnibus accession number
GSE94772) were normalized using pair-wise rank-invariant normalization
in software dchip_2010_01.exe and analyzed using software. Changes in
gene expression between the sample groups were determined using the
following criteria: differentially expressed genes between WT in normoxia
(A) and hypoxia (B), and HIF1α-KD MDCK cells in normoxia (C) and
hypoxia (D) were identified by the comparison option of the dchip_2010_01
software. The filtering criteria for this analysis were (1) fold change D/B or
B/D≥2, (2) lower confidence bound of fold change D−B or B−D=100, (3)
P value for paired t-test <0.05. Differently expressed genes were analyzed
by the DAVID Bioinformatics Resources.
RNA isolation and qRT-PCR
2DMDCK cells were cultured in normoxic conditions for 24 h, followed by
24 h in hypoxic or normoxic conditions. Total RNA was isolated from the
2D and 3D cells by using an RNeasy Kit (Qiagen, Hilden, Germany),
according to the manufacturer’s protocol. The total RNA was reverse-
transcribed into cDNA using an iScript cDNA synthesis kit (Bio-Rad
Laboratories, Hercules, CA). Quantitative real-time PCR (qRT-PCR) was
performed using iTaq Universal SYBR Green Supermix (Bio-Rad
Laboratories, Hercules, CA) and a CFX96 Touch real-time PCR detection
system. Primer sequences are listed in Table S4. Expression levels were
normalized to that of TATA box-binding protein.
Western blotting
2D MDCK cells were seeded at a density of 7.5×105 cells in 10-cm diameter
dishes and cultured in normoxic conditions for 24 h and then transferred to
hypoxic conditions for 3, 6, 12, 18 or 24 h. Protein was isolated using RIPA
lysis buffer (25 mMTris-HCl pH7.8, 150 mMNaCl, 0.1%SDS, 0.5% sodium
deoxycholate and 1%Triton X-100). Primary antibodies against the following
proteinswere used as follows:HIF1α (NB100-479, 1:2000,NovusBiological,
Littleton, CO), TGFβR1 (ab31013, 1:1000, Abcam,Abcam, Cambridge, UK),
TGFβR2 (ab186838, 1:500, Abcam), Smad2 (5339S, 1:1000, Cell Signaling,
Danvers, MA), pSmad2 (3108L, 1:1000, Cell Signaling), LTBP1 (sc-28132,
1:200, Santa Cruz Biotechnology, Dallas, TX), vimentin (V6630, 1:1000,
Sigma-Aldrich), ZO-1 (339100, 1:500, Invitrogen), E-cadherin (rr1, 1:1000,
Developmental Studies Hybridoma Bank), ItgαV (ab1930, 1:1000, Millipore,
Burlington, MA) and α-tubulin (T6199, 1:20,000, Sigma-Aldrich).
Quantification of western blot data was performed from at least three
independent blots. First, for every experiment, the intensities of protein
bands were normalized relative to that of a loading control (α-tubulin).
Secondly, normalized band intensities were adjusted relative to the average
of the replicates of an appropriate sample in each experiment. For the
quantification in Fig. 1A, hypoxic HIF1α levels were set to 100% and other
samples are shown relative to this. In Figs 2C,E,H,J, 3G, and 5D, arbitrary
proteins levels are shown relative to protein levels in normoxic control cells,
which were adjusted to 1. Quantification of the hypoxia-induced Smad2
phosphorylation (Figs 3F and 8B) was achieved by first adjusting α-tubulin
normalized intensities (for both Smad2 and pSmad2) relative to Smad2
value in normoxic control cells, which was set to 1. Then the value in
hypoxia was divided with that found in normoxia, separately for each
replicate. In all of the above cases graphs show mean±s.d. as described in
each figure legend. Quantifications in Fig. 3D,E represent the value from a
single blot (Fig. 3C) where α-tubulin normalized intensities for each protein
are shown relative to normoxic levels in control cells, which were set to 1.
Microscopy and image acquisition
Confocal images were acquired at RT using an Olympus FluoView-1000
laser-scanning confocal microscopewith an 100×UPlanSApo (NA 1.40) oil
immersion objective (Olympus, Tokyo, Japan). Sequential scans were
performed using 405 nm, 488 nm and 543 nm laser lines, for fluorophore
excitation, coupled with DAPI (430–470 nm), GFP (505–525 nm) and Cy3
(560LP) emission filters, respectively. Images were collected with the
FV10-ASW software (Olympus, Tokyo, Japan) and imported into Adobe
Photoshop CS (Adobe Systems, San José, CA).
Measurement of TGFβ level
The concentration of total and active TGFβ1 in culture medium was
determined by means of the TGFβ1 Emax ImmunoAssay System (G7590,
Promega, Madison, WI) in Nunc immuno 96 well plates (442404, Sigma-
Aldrich) according to the manufacturer’s instructions with the following
modifications. Cells were cultured first for 24 h in minimal essential
medium (MEM; Gibco, Gaithersburg, MD) containing 5% fetal bovine
serum (FBS, Thermo Fisher Scientific, Waltham, MA) after which they
were washed with PBS and cultured for an additional 24 h in MEM without
FBS. 100 ml samples of the culture medium were collected in sterile tubes,
passed through a 0.45-µm filter to remove cell debris, concentrated to 400 µl
using an Amicon Ultra-15 Centrifugal Filter Unit with Ultracel-10
membrane (UFC901024, Merck Millipore, Burlington, MA) and frozen
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until analysis. To detect total TGFβ1, half of each sample was acidified with
HCl to pH 3.0 for 20 min at RT and then neutralized to pH 7.6 with NaOH.
Active TGFβ1 was detected in the other half of the sample according to the
manufacturer’s instructions. Samples were then diluted 1:2 in the provided
sample buffer and incubated for 90 min at RT with shaking. The amount of
latent TGFβ1 was determined as a subtraction of the active portion from the
total amount of TGFβ1. Plates were read in a Multilabel Counter 1420
VICTOR3 V (Perkin Elmer, Waltham, MA) at 450 nm.
Statistical analysis
Statistical analyses for comparisons between two groups were performed
using Student’s two-tailed t-test and denoted as *P<0.05; **P<0.01;
***P<0.001 in all experiments.
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